Home Salud NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in...

NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease

0

In this audio interview, Editor-in-Chief Eric Rubin and Deputy Editor Jane Leopold discuss research being presented at the 2024 American Heart Association Scientific Sessions. . . .

​   The New England Journal of Medicine: Search Results in Cardiology

Salir de la versión móvil